Shantha Biotechnics' ShanIPV Poliomyelitis Vaccine Prequalified by WHO



[ad_1]

Sanofi Pasteur announced Wednesday that the World Health Organization (WHO) had pre-qualified the ShanIPV, an inactivated polio vaccine.

This vaccine allows the purchase of ShanIPV vaccine by UN agencies, Sanofi Pasteur and Shantha Biotechnics. said in a joint statement.

The polio vaccine was developed by the arm of Sanofi Pasteur Shantha Biotechnics.

Shantha Biotechnics Executive Director and Chief Operating Officer, Mahesh Bhalgat, said: "Prequalification of a vaccine by WHO is a rigorous process in which WHO reviews the process production, quality control procedures, consistency testing of different batches and works closely with the national regulatory authority responsible in this process. "

Over the last two decades, Sanofi Pasteur has responded to the needs of the Indian population in immunization by offering products of the highest quality. Today, the only two vaccines available in India, pre-qualified by WHO, are both provided by Sanofi Pasteur (ShanIPV and Hexaxim), "said Jean-Pierre Baylet, National Director of Sanofi Pasteur , India and South Asia.

Acquisition of Shantha Biotechnics by Sanofi Pasteur Holding in 2009.

(This story has not been modified by the staff of Business Standard and is generated automatically from time to time. a syndicated flow.)

[ad_2]
Source link